Stock listing
Imunon, Inc.
Selected listing: 0HUZ · LSE · USD · GB
Imunon, Inc. (LSE:0HUZ), Health Technology. Latest release Sep 29, 2026: IMUNON Converts $1.2 Million of Debt-to-Equity.
- Ticker
- LSE:0HUZ
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- LSE
- Currency
- USD
Latest news from Imunon, Inc.
IMUNON Converts $1.2 Million of Debt-to-Equity
September 28, 2026
IMUNON Reports Independent Data Monitoring Committee Recommends Continued Phase 2 Development of IMNN-001 Following Favorable Safety Review
September 22, 2026
IMUNON Enters Cooperative Research and Development Agreement with National Cancer Institute to Advance Clinical Development of IMNN-001
September 10, 2026
IMUNON Announces Full Agenda and Speaker Lineup Ahead of 2026 R&D Day Highlighting IMNN-001 Clinical Progress
September 9, 2026
IMUNON to Host 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial and the Clinical Potential of IMNN-001
August 26, 2026
Events
Research Imunon, Inc.
Alternate listings
IMNN:NASDAQ
US · USD
Alternate listing for Imunon, Inc.; the primary context on this page is 0HUZ:LSE.
A41CNR:LS
DE · EUR
Alternate listing for Imunon, Inc.; the primary context on this page is 0HUZ:LSE.
A41CNR:LSX
DE · EUR
Alternate listing for Imunon, Inc.; the primary context on this page is 0HUZ:LSE.
CBO0:TRADEGATE
DE · EUR
Alternate listing for Imunon, Inc.; the primary context on this page is 0HUZ:LSE.
CBO0:GETTEX
DE · EUR
Alternate listing for Imunon, Inc.; the primary context on this page is 0HUZ:LSE.
IMNN:BOATS
US · USD
Alternate listing for Imunon, Inc.; the primary context on this page is 0HUZ:LSE.
CBO0:SWB
DE · EUR
Alternate listing for Imunon, Inc.; the primary context on this page is 0HUZ:LSE.
CBO0:DUS
DE · EUR
Alternate listing for Imunon, Inc.; the primary context on this page is 0HUZ:LSE.
CBO0:FWB
DE · EUR
Alternate listing for Imunon, Inc.; the primary context on this page is 0HUZ:LSE.
CBO0:MUN
DE · EUR
Alternate listing for Imunon, Inc.; the primary context on this page is 0HUZ:LSE.